How the U.S. Government Botched Its Multibillion-Dollar Plan to Beat Childhood Disease
John Tozzi and Alex Wayne (Bloomberg BusinessWeek)
A Testable Idea Is Better than a Good Idea
Michael Schrage (Harvard Business Review)
BioCryst Hits Trifecta For Flu, Ebola, and Hereditary Angioedema
David Kroll (Forbes)
Drug pricing is the new Big Pharma giant-killer
Frank David (Pharmagellan)
2014 New Drug Approvals Hit 18-Year High
Bernard Munos (Forbes)
Recapping the record 41 FDA product approvals last year.
By ‘Editing’ Plant Genes, Companies Avoid Regulation
Andrew Polack (New York Times)